"","Num","POD","SD","%","Genes","KE"
"GO:0000003","1","0.000147574",NA,"0.49","406626","REDUCED REPRODUCTIVE SUCCESS; REPRODUCTIVE FAILURE"
"GO:0044703","1","0.000147574",NA,"0.86","406626","N/A REPRODUCTIVE FAILURE"
"ABNORMAL RESPIRATORY SYSTEM MORPHOLOGY","1","0.000147574",NA,"0.68","406626","INCREASED RESPIRATORY DISTRESS/ARREST"
"INCREASED SUSCEPTIBILITY TO FRACTURES","1","0.000147574",NA,"2.86","406626","INCREASED DISEASE SUSCEPTIBILITY"
"MORTALITY AGING","1","0.000147574",NA,"3.85","406626","REDUCED FITNESS OR EVEN MORTALITY ACIDOSIS HYPOVOLEMIC SHOCK AND ORGAN DYSFUNCTION; INCREASE MORTALITY; INCREASED MORTALITY"
"ABNORMAL LUNG MORPHOLOGY","1","0.000147574",NA,"0.78","406626","INCREASE ADENOMAS/CARCINOMAS BRONCHIOLOALVEOLAR"
"GO:0001775","1","0.00030946",NA,"0.51","100002928","ACTIVATION DENDRITIC CELLS"
"GO:0001816","1","0.00030946",NA,"0.83","100002928","NON-NEURONAL PRODUCTION OF TNF EPITHELIAL IRRITATION; PRODUCTION OF NERVE GROWTH FACTOR  EPITHELIAL IRRITATION; NON-NEURONAL PRODUCTION OF IL-8/CXCL1 EPITHELIAL IRRITATION"
"GO:0019904","1","0.00030946",NA,"0.81","100002928","N/A INTERFERENCES WITH SH-/SELEN-PROTEINS"
"GO:0003158","1","0.000652383",NA,"4.17","30493","IMPAIRMENT ENDOTHELIAL NETWORK"
"GO:0043542","1","0.000652383",NA,"2.86","30493","INCREASED MIGRATION ENDOTHELIAL CELLS"
"GO:0048813","1","0.000652383",NA,"7.69","30493","ABERRANT DENDRITIC MORPHOLOGY"
"GO:0072358","1","0.000652383",NA,"0.9","30493","ALTERED CARDIOVASCULAR DEVELOPMENT/FUNCTION"
"POSITIVE REGULATION OF GENE EXPRESSION","1","0.000652383",NA,"0.55","30493","ALTERED GENE EXPRESSION"
"G TGF BETA SIGNALING PATHWAY","1","0.000652383",NA,"1.47","30493","ACTIVATION TGF-BETA PATHWAY; UP REGULATION TGFBETA1 EXPRESSION"
"GO:0019882","2","0.000733489714100341","0.0967970623135965","3.39","30387, 30649","GENERATION OF NOVEL EPITOPES  ANTIGEN PRESENTATION"
"GO:1903009","2","0.000733489714100341","0.0967970623135965","5.88","30387, 30649","DECREASE GTPCH-1"
"CTOME CELLULAR RESPONSE TO HYPOXIA","2","0.000733489714100341","0.0967970623135965","4.65","30387, 30649","N/A HYPOXIA"
"GO:0040011","3","0.00111138864592863","0.233407458591723","1.32","100002928, 30493, 286830","INCREASED LOCOMOTION; INCREASED MUSCULAR WAVES IN FOOT; DECREASED LOCOMOTION"
"GO:0048870","3","0.00111138864592863","0.233407458591723","1.5","100002928, 30493, 286830","INCREASED MOTILITY"
"ABNORMAL BLOOD POTASSIUM CONCENTRATION","1","0.001617222",NA,"8.33","327379","INCREASED BLOOD POTASSIUM CONCENTRATION"
"ABNORMAL CARDIAC TEST","1","0.001617222",NA,"7.69","327379","INCREASED CARDIAC ARRTHYMIA"
"BRADYCARDIA","1","0.001617222",NA,"16.67","327379","INCREASED ATRIOVENTRICULAR BLOCK AND BRADYCARDIA"
"VENTRICULAR ARRHYTHMIA","1","0.001617222",NA,"14.29","327379","OCCURRENCE CARDIAC ARRHYTHMIA"
"REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY","1","0.001617222",NA,"12.5","327379","INHIBITION INDUCIBLE NITRIC OXIDE SYNTHASE BY METABOLITE CGA 265307"
"G OOCYTE MEIOSIS","1","0.001617222",NA,"2.5","327379","REDUCED MEIOTIC PROPHASE I/METAPHASE I TRANSITION OOCYTE"
"POSITIVE REGULATION OF CALCIUM ION TRANSPORT","1","0.001617222",NA,"3.12","327379","INCREASE CA++ INTRACELLULAR; INCREASED INTRACELLULAR CALCIUM OVERLOAD"
"REGULATION OF WNT SIGNALING PATHWAY","4","0.00172479890450266","0.114572118527593","5.06","30387, 30649, 406533, 192307","INHIBITION WNT PATHWAY"
"GO:0046903","2","0.0017495264688938","0.53196774249755","0.87","100002928, 393664","SUPPRESSION VLDL SECRETION; INCREASE MUCIN PRODUCTION; INCREASED SECRETION OF LOCAL GROWTH FACTORS"
"GO:0046983","3","0.00177219713560571","0.136427797810165","1.52","30493, 114426, 791146","DIMERIZATION AHR/ARNT; REDUCED DIMERIZATION ARNT/HIF1-ALPHA"
"REGULATION OF CELL DEATH","4","0.00201058063814417","0.11650387076437","1.49","30493, 30649, 791146, 334582","N/A CELL INJURY/DEATH"
"HYPERACTIVITY","1","0.002011545",NA,"2","114426","INDUCTION ATAXIA PARALYSIS OR HYPERACTIVITY; INCREASED ATAXIA PARALYSIS OR HYPERACTIVITY; N/A ATAXIA PARALYSIS OR HYPERACTIVITY"
"IMMUNOLOGIC HYPERSENSITIVITY","1","0.002011545",NA,"4.35","114426","INCREASE ALLERGIC RESPIRATORY HYPERSENSITIVITY RESPONSE"
"G GLUTATHIONE METABOLISM","1","0.002011545",NA,"12.5","114426","DEPLETION GSH"
"GO:0050673","2","0.00210618576361274","0.359913135408635","2.44","30493, 286830","INCREASE REGENERATIVE CELL PROLIFERATION TUBULAR EPITHELIAL CELLS; INCREASE REGENERATIVE CELL PROLIFERATION TERMINAL BRONCHIOLAR EPITHELIAL CELLS"
"GO:0030163","6","0.00214286614615172","0.0679047526596624","3.92","30387, 30649, 114426, 406533, 323883, 192307","INCREASED CATABOLISM OF MUSCLE PROTEIN"
"GO:0005488","12","0.00230622004715575","0.0489134139931386","1.12","406626, 100002928, 30493, 327379, 30732, 406533, 791146, 323883, 192307, 286830, 192305, 393664","INCREASED BINDING OF CHEMICALS TO 2U SERUM"
"REGULATION OF PROTEOLYSIS","3","0.00254771310092397","0.125980521745882","2.68","30649, 406533, 192307","IMPAIRED PROTEOSTASIS"
"GO:0007051","1","0.002916558",NA,"3.7","406533","DISORGANIZATION SPINDLE"
"MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION","1","0.002916558",NA,"10","406533","DEPOLYMERIZATION MICROTUBULE"
"ABNORMAL NASAL MORPHOLOGY","2","0.00321744708680967","0.144236815587084","1.29","114426, 436647","INCREASE SITE OF CONTACT NASAL TUMORS"
"GO:0003824","2","0.00395478718769544","0.207601859971704","3.08","114426, 368912","DECREASED DHB4/HSD17B4; DECREASE INCORPORATION OF ACTIVE IODIDE INTO IODOTYROSINES; INHIBITION PROLYL HYDROXYLASES; INHIBITION UROD; DECREASE AKT/ENOS ACTIVITY; INHIBITION DEIODINASE 2; INHIBITION DEIODINASE 1; INHIBITION IODOTYROSINE DEIODINASE IYD; INHIBITION DEIODINASE 3; INHIBITION DUAL OXIDASE; INDUCTION UPREGULATION OF GLUCURONYLTRANSFERASE ACTIVITY"
"GO:0016055","2","0.00405585954892696","0.101266381334767","8.7","406533, 192307","ALTERATION WNT PATHWAY"
"GO:0016310","2","0.00405585954892696","0.101266381334767","1.6","406533, 192307","ACTIVATION SP1"
"NEGATIVE REGULATION OF FAT CELL PROLIFERATION","1","0.004241346",NA,"25","791146","INDUCTION SUSTAINED CELL PROLIFERATION"
"UPPER MOTOR NEURON DYSFUNCTION","3","0.00473782464201791","0.107838888202931","0.63","114426, 286830, 368912","DECREASE HISTAMINERGIC NEURON EXCITATION; OCCURRENCE CYTOPLASMIC VACUOLIZATION BILE DUCT CELL; OCCURRENCE CYTOPLASMIC VACUOLIZATION KUPFFER CELL"
"BREAST CANCER PATHWAY","2","0.00489102012685636","0.0437669026054331","1.75","791146, 192307","N/A BREAST CANCER"
"GO:0045444","1","0.005146276",NA,"2.44","436647","INCREASED ADIPOGENESIS"
"NCRNAS INVOLVED IN WNT SIGNALING IN HEPATOCELLULAR CARCINOMA","1","0.005640209",NA,"2.08","192307","INCREASE HERITABLE MUTATIONS IN OFFSPRING"
"GO:0007612","1","0.005874811",NA,"4.17","334582","IMPAIRMENT LEARNING AND MEMORY"
"GO:0099536","1","0.005874811",NA,"0.9","334582","DECREASED NEURONAL NETWORK FUNCTION IN ADULT BRAIN; DECREASED NEURONAL NETWORK FUNCTION IN ADULT BRAIN"
"GO:1903008","1","0.005874811",NA,"7.69","334582","DISRUPTION LYSOSOME"
"PYRUVATE METABOLIC PROCESS","1","0.005874811",NA,"1.79","334582","INHIBITION 4-HYDROXYPHENYL-PYRUVATE DIOXYGENASE HPPD ENZYME"
"GO:0005102","1","0.006799715",NA,"0.48","286830","DECREASED TESTOSTERONE BINDING TO ANDROGEN RECEPTOR HYPOTHALAMUS"
"GO:0009790","1","0.006799715",NA,"0.59","286830","DEFECT OF EMBRYOGENESIS"
"GO:0006629","1","0.007775288",NA,"0.49","368912","ALTERATION LIPID METABOLISM"
"GO:0006635","1","0.007775288",NA,"5","368912","DECREASED PEROXISOMAL FATTY ACID BETA OXIDATION OF FATTY ACIDS; DECREASED MITOCHONDRIAL FATTY ACID BETA OXIDATION; DECREASED MITOCHONDRIAL FATTY ACID BETA-OXIDATION; INHIBITION MITOCHONDRIAL FATTY ACID BETA-OXIDATION"
"ABNORMALITY OF BLOOD AND BLOOD FORMING TISSUES","1","0.007775288",NA,"0.25","368912","DAMAGING RED BLOOD CELLS; HEMOLYSIS"
"DECREASED BODY WEIGHT","1","0.007775288",NA,"0.44","368912","DECREASED BODY WEIGHT"
"ABNORMALITY OF THE MITOCHONDRION","1","0.007775288",NA,"0.79","368912","INJURY MITOCHONDRIA; DAMAGING MITOCHONDRIA; N/A MITOCHONDRIAL DYSFUNCTION 1"
"GO:0006915","1","0.008313209",NA,"3.23","140621","CHANGES/INHIBITION CELLULAR HOMEOSTASIS AND APOPTOSIS; DECREASED APOPTOSIS EPITHELIAL CELLS; INCREASED APOPTOSIS DECREASED LEYDIG CELLS"
"GO:0044414","1","0.009890916",NA,"2.5","393664","SUPPRESSION IMMUNE SYSTEM"
"ABNORMAL NEURON MORPHOLOGY","1","0.009890916",NA,"6.25","393664","HYPERPOLARISATION NEURON"
"CTOME ACTIVATION OF AMPK DOWNSTREAM OF NMDARS","1","0.009890916",NA,"7.69","393664","INHIBITION NMDARS; OVERACTIVATION NMDARS"
